Abstract: A method for separating liquids is disclosed. A feed stream is passed into a separator. The feed stream comprising an organic compound, carbon dioxide, and oxides selected from the group consisting of sulfur oxides, nitrogen oxides, ozone and combinations thereof. A portion an organic-rich stream is separated from a portion of an inorganic-rich stream through separation by gravity. The organic-rich stream contains a portion of the organic compound and a first portion of the carbon dioxide. The inorganic-rich stream contains a portion of the oxides and a second portion of the carbon dioxide.

Abstract: In general, scapular tethers and methods of using scapular tethers are provided. A tether is configured to be implanted in a body of a patient and to control movement of the patient's scapula. In an exemplary embodiment, the tether is configured to be attached to at least one body structure in a patient. The tether includes a flexible member configured to, when implanted in the patient, flex in response to movement of the patient's scapula accompanying arm movement of the patient.

Abstract: Implants are provided. In one exemplary embodiment, an implant includes a spacer configured to be implanted within a joint. The spacer includes an elongated central body extending from a first end to a second end with a longitudinal axis extending therebetween, and first and second wings extending from the first and second ends of the elongated central body, respectively. The elongated central body has a first maximum height in a direction transverse to the longitudinal axis, and each of the first and second wings has a maximum height greater than the first maximum height. When implanted and in the inflated state, at least one of the first wing and the second wing is configured to mechanically interlock with a portion of the anatomy to thereby self-anchor the spacer to the joint and inhibit migration of the spacer. Implant systems and methods for biomechanically augmenting muscle function are also provided.

Abstract: In general, scapular tethers and methods of using scapular tethers are provided. A tether is configured to be implanted in a body of a patient and to control movement of the patient's scapula. In an exemplary embodiment, the tether is configured to be attached to at least one body structure in a patient. The tether includes a flexible member configured to, when implanted in the patient, flex in response to movement of the patient's scapula accompanying arm movement of the patient.

Abstract: The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Abstract: The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Abstract: A variable moment of inertia (MOI) bat fitting device that is used to measure a hitter's output at various weight distributions.

Abstract: The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Abstract: The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes.

Abstract: The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Abstract: The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Abstract: The present invention provides UTI fusion proteins, DNA sequences for producing the same, and pharmaceutical compositions and methods of using the same.

Abstract: The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes.

Abstract: Humanized Ep-CAM-targeting antibodies and methods of making and using the same are provided.

Abstract: The present application relates to optimized IgG immunoglobulin variants, engineering methods for their generation, and their application, particularly for therapeutic purposes.

Abstract: Humanized Ep-CAM-targeting antibodies and methods of making and using the same are provided.

Abstract: The present application relates to optimized IgG immunoglobulin engineering methods for their generation, and their application, particularly for therapeutic purposes.

Abstract: Design and production of immunoglobulin Fc domains including variants to stabilize their monomeric forms are provided.

Abstract: The invention relates to novel methods for engineering protein sequences using structural and homology information.

Abstract: The present invention relates to soluble, recombinant CD40L variant proteins that may be expressed solubly in E. coli. The variants of the present invention may substantially reduced binding to alpha IIb-beta3 integrin, act as CD40L antagonists or agonists, and methods for generating the same.